Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
This is a two-part study designed to evaluate the effect of Estetrol (E4) 15 or 20 mg, or placebo on the severity and frequency of vasomotor symptoms (VMS) (Efficacy Study Part) and the safety of E4 20 mg (Safety Study Part).
Epistemonikos ID: e0396ce72e21105daa8d5be572c03e79f63d89ca
First added on: May 22, 2024